rs2306875

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001378452.1(ITPR1):​c.2007G>A​(p.Lys669Lys) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.668 in 1,569,864 control chromosomes in the GnomAD database, including 354,237 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.67 ( 34961 hom., cov: 32)
Exomes 𝑓: 0.67 ( 319276 hom. )

Consequence

ITPR1
NM_001378452.1 splice_region, synonymous

Scores

3
Splicing: ADA: 0.5656
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 4.61

Publications

26 publications found
Variant links:
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
ITPR1 Gene-Disease associations (from GenCC):
  • aniridia-cerebellar ataxia-intellectual disability syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, ClinGen, Orphanet
  • spinocerebellar ataxia type 29
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • spinocerebellar ataxia type 15/16
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001378452.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 3-4670729-G-A is Benign according to our data. Variant chr3-4670729-G-A is described in ClinVar as Benign. ClinVar VariationId is 129298.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.69 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378452.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ITPR1
NM_001378452.1
MANE Select
c.2007G>Ap.Lys669Lys
splice_region synonymous
Exon 20 of 62NP_001365381.1Q14643-1
ITPR1
NM_001168272.2
c.1962G>Ap.Lys654Lys
splice_region synonymous
Exon 19 of 61NP_001161744.1Q14643-2
ITPR1
NM_001099952.4
c.2007G>Ap.Lys669Lys
splice_region synonymous
Exon 20 of 59NP_001093422.2Q14643-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ITPR1
ENST00000649015.2
MANE Select
c.2007G>Ap.Lys669Lys
splice_region synonymous
Exon 20 of 62ENSP00000497605.1Q14643-1
ITPR1
ENST00000354582.12
TSL:5
c.2007G>Ap.Lys669Lys
splice_region synonymous
Exon 20 of 62ENSP00000346595.8A0A3F2YNW8
ITPR1
ENST00000648266.1
c.2007G>Ap.Lys669Lys
splice_region synonymous
Exon 20 of 62ENSP00000498014.1A0A3B3IU04

Frequencies

GnomAD3 genomes
AF:
0.675
AC:
102489
AN:
151924
Hom.:
34924
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.697
Gnomad AMI
AF:
0.705
Gnomad AMR
AF:
0.701
Gnomad ASJ
AF:
0.610
Gnomad EAS
AF:
0.355
Gnomad SAS
AF:
0.637
Gnomad FIN
AF:
0.692
Gnomad MID
AF:
0.596
Gnomad NFE
AF:
0.684
Gnomad OTH
AF:
0.646
GnomAD2 exomes
AF:
0.648
AC:
129425
AN:
199708
AF XY:
0.643
show subpopulations
Gnomad AFR exome
AF:
0.684
Gnomad AMR exome
AF:
0.716
Gnomad ASJ exome
AF:
0.600
Gnomad EAS exome
AF:
0.354
Gnomad FIN exome
AF:
0.696
Gnomad NFE exome
AF:
0.669
Gnomad OTH exome
AF:
0.647
GnomAD4 exome
AF:
0.668
AC:
946701
AN:
1417822
Hom.:
319276
Cov.:
29
AF XY:
0.666
AC XY:
468217
AN XY:
702542
show subpopulations
African (AFR)
AF:
0.688
AC:
22441
AN:
32602
American (AMR)
AF:
0.711
AC:
27596
AN:
38830
Ashkenazi Jewish (ASJ)
AF:
0.601
AC:
15315
AN:
25492
East Asian (EAS)
AF:
0.348
AC:
13389
AN:
38522
South Asian (SAS)
AF:
0.640
AC:
52162
AN:
81442
European-Finnish (FIN)
AF:
0.698
AC:
36006
AN:
51620
Middle Eastern (MID)
AF:
0.609
AC:
3438
AN:
5646
European-Non Finnish (NFE)
AF:
0.680
AC:
737973
AN:
1084686
Other (OTH)
AF:
0.651
AC:
38381
AN:
58982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
13697
27394
41091
54788
68485
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18964
37928
56892
75856
94820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.675
AC:
102584
AN:
152042
Hom.:
34961
Cov.:
32
AF XY:
0.673
AC XY:
49998
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.697
AC:
28883
AN:
41450
American (AMR)
AF:
0.701
AC:
10720
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.610
AC:
2114
AN:
3466
East Asian (EAS)
AF:
0.354
AC:
1832
AN:
5170
South Asian (SAS)
AF:
0.637
AC:
3066
AN:
4814
European-Finnish (FIN)
AF:
0.692
AC:
7325
AN:
10580
Middle Eastern (MID)
AF:
0.616
AC:
180
AN:
292
European-Non Finnish (NFE)
AF:
0.684
AC:
46468
AN:
67964
Other (OTH)
AF:
0.644
AC:
1356
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1656
3312
4969
6625
8281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.670
Hom.:
99226
Bravo
AF:
0.671
Asia WGS
AF:
0.536
AC:
1864
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
2
not specified (2)
-
-
2
Spinocerebellar ataxia type 29 (2)
-
-
1
Autosomal dominant cerebellar ataxia (1)
-
-
1
Gillespie syndrome (1)
-
-
1
Spinocerebellar ataxia type 15/16 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
21
DANN
Benign
0.89
PhyloP100
4.6
Mutation Taster
=30/70
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.57
dbscSNV1_RF
Benign
0.48
SpliceAI score (max)
0.34
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.34
Position offset: 29

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2306875;
hg19: chr3-4712413;
COSMIC: COSV56976735;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.